TY - JOUR
T1 - Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray
AU - Watanabe, Toshiaki
AU - Kobunai, Takashi
AU - Toda, Etsuko
AU - Kanazawa, Takamitsu
AU - Kazama, Yoshihiro
AU - Tanaka, Junichiro
AU - Tanaka, Toshiaki
AU - Yamamoto, Yoko
AU - Hata, Keisuke
AU - Kojima, Tetsu
AU - Yokoyama, Tadashi
AU - Konishi, Tsuyoshi
AU - Okayama, Yoshihiro
AU - Sugimoto, Yoshikazu
AU - Oka, Toshinori
AU - Sasaki, Shin
AU - Ajioka, Yohichi
AU - Muto, Tetsuichiro
AU - Nagawa, Hirokazu
PY - 2007/1/15
Y1 - 2007/1/15
N2 - Purpose: Ulcerative colitis (UC) is associated with a high risk of colorectal cancer. To identify genes that could predict the development of cancer in UC, we conducted a DNA microarray analysis using nonneoplastic rectal mucosa of UC patients. Experimental Design: Gene expression in nonneoplastic mucosa of 53 UC patients were examined. Gene expression profiles were examined using human Genome U133 Plus 2.0 gene chip array (Affymetrix). Among 53 UC patients, 10 had UC-associated cancer (UC-Ca group) whereas 43 did not (UC-NonCa group). Results: By comparing gene expression profiles of nonneoplastic rectal mucosae between the UC-Ca and UC-NonCa groups, we could identify 40 genes that were differentially expressed between two groups. The list of discriminating genes included low-density lipoprotein receptor-related protein (LRP5 and LRP6). Previous studies suggested that LRP5 and LRP6 expression promotes cancer cell proliferation and tumorigenesis and are considered as candidate oncogenes. In the present study, both LRP5 and LRP6 showed significantly higher expression in the UC-Ca group, which suggests the importance of these genes in the development of UC-associated colorectal cancers. With the 40 selected discriminating genes, we did class prediction of the development of colorectal neoplasms in UC patients. Using the k-nearest neighbor method and the support vector machine, we could predict the development of UC-associated neoplasms with an accuracy of 86.8% and 98.1%, respectively. Conclusions: These findings have important implications for the early detection of malignant lesions in UC and may provide directions for future research into the molecular mechanisms of UC-associated cancer.
AB - Purpose: Ulcerative colitis (UC) is associated with a high risk of colorectal cancer. To identify genes that could predict the development of cancer in UC, we conducted a DNA microarray analysis using nonneoplastic rectal mucosa of UC patients. Experimental Design: Gene expression in nonneoplastic mucosa of 53 UC patients were examined. Gene expression profiles were examined using human Genome U133 Plus 2.0 gene chip array (Affymetrix). Among 53 UC patients, 10 had UC-associated cancer (UC-Ca group) whereas 43 did not (UC-NonCa group). Results: By comparing gene expression profiles of nonneoplastic rectal mucosae between the UC-Ca and UC-NonCa groups, we could identify 40 genes that were differentially expressed between two groups. The list of discriminating genes included low-density lipoprotein receptor-related protein (LRP5 and LRP6). Previous studies suggested that LRP5 and LRP6 expression promotes cancer cell proliferation and tumorigenesis and are considered as candidate oncogenes. In the present study, both LRP5 and LRP6 showed significantly higher expression in the UC-Ca group, which suggests the importance of these genes in the development of UC-associated colorectal cancers. With the 40 selected discriminating genes, we did class prediction of the development of colorectal neoplasms in UC patients. Using the k-nearest neighbor method and the support vector machine, we could predict the development of UC-associated neoplasms with an accuracy of 86.8% and 98.1%, respectively. Conclusions: These findings have important implications for the early detection of malignant lesions in UC and may provide directions for future research into the molecular mechanisms of UC-associated cancer.
UR - http://www.scopus.com/inward/record.url?scp=33846864003&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846864003&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-06-0753
DO - 10.1158/1078-0432.CCR-06-0753
M3 - Article
C2 - 17255260
AN - SCOPUS:33846864003
SN - 1078-0432
VL - 13
SP - 415
EP - 420
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 2 I
ER -